These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 19033861

  • 1. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
    Taube JM, Begum S, Shi C, Eshleman JR, Westra WH.
    Am J Surg Pathol; 2009 Apr; 33(4):568-71. PubMed ID: 19033861
    [Abstract] [Full Text] [Related]

  • 2. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis.
    Wu J, Rosenbaum E, Begum S, Westra WH.
    Am J Dermatopathol; 2007 Dec; 29(6):534-7. PubMed ID: 18032947
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
    Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG.
    Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
    [Abstract] [Full Text] [Related]

  • 4. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
    Holt JB, Sangueza OP, Levine EA, Shen P, Bergman S, Geisinger KR, Creager AJ.
    Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
    [Abstract] [Full Text] [Related]

  • 5. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    Indsto JO, Kumar S, Wang L, Crotty KA, Arbuckle SM, Mann GJ.
    J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
    [Abstract] [Full Text] [Related]

  • 6. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
    Chen G, Dudley J, Tseng LH, Smith K, Gurda GT, Gocke CD, Eshleman JR, Lin MT.
    Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
    [Abstract] [Full Text] [Related]

  • 7. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.
    Cohen Y, Rosenbaum E, Begum S, Goldenberg D, Esche C, Lavie O, Sidransky D, Westra WH.
    Clin Cancer Res; 2004 May 15; 10(10):3444-7. PubMed ID: 15161700
    [Abstract] [Full Text] [Related]

  • 8. Absence of V599E BRAF mutations in desmoplastic melanomas.
    Davison JM, Rosenbaum E, Barrett TL, Goldenberg D, Hoque MO, Sidransky D, Westra WH.
    Cancer; 2005 Feb 15; 103(4):788-92. PubMed ID: 15641040
    [Abstract] [Full Text] [Related]

  • 9. BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients.
    Kanitakis J, Baldassini S, Lora V, Euvrard S.
    Eur J Dermatol; 2010 Feb 15; 20(2):167-71. PubMed ID: 19919912
    [Abstract] [Full Text] [Related]

  • 10. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
    Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA, Kefford RF.
    J Clin Oncol; 2011 Apr 01; 29(10):1239-46. PubMed ID: 21343559
    [Abstract] [Full Text] [Related]

  • 11. BRAF mutations in conjunctival melanoma.
    Gear H, Williams H, Kemp EG, Roberts F.
    Invest Ophthalmol Vis Sci; 2004 Aug 01; 45(8):2484-8. PubMed ID: 15277467
    [Abstract] [Full Text] [Related]

  • 12. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
    Dadzie OE, Yang S, Emley A, Keady M, Bhawan J, Mahalingam M.
    Br J Dermatol; 2009 Feb 01; 160(2):368-75. PubMed ID: 18945298
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics and survival data of melanoma patients with nevus cell aggregates within sentinel lymph nodes.
    Gambichler T, Scholl L, Stücker M, Bechara FG, Hoffmann K, Altmeyer P, Othlinghaus N.
    Am J Clin Pathol; 2013 May 01; 139(5):566-73. PubMed ID: 23596107
    [Abstract] [Full Text] [Related]

  • 14. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E, Egyházi S, Omholt K, Månsson-Brahme E, Platz A, Hansson J, Lundeberg J.
    Melanoma Res; 2006 Dec 01; 16(6):471-8. PubMed ID: 17119447
    [Abstract] [Full Text] [Related]

  • 15. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
    Mihic-Probst D, Perren A, Schmid S, Saremaslani P, Komminoth P, Heitz PU.
    Anticancer Res; 2004 Dec 01; 24(4):2415-8. PubMed ID: 15330192
    [Abstract] [Full Text] [Related]

  • 16. No Evidence for BRAF as a melanoma/nevus susceptibility gene.
    Jackson S, Harland M, Turner F, Taylor C, Chambers PA, Randerson-Moor J, Swerdlow AJ, dos Santos Silva I, Beswick S, Bishop DT, Newton Bishop JA.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 01; 14(4):913-8. PubMed ID: 15824163
    [Abstract] [Full Text] [Related]

  • 17. Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region.
    Amanuel B, Grieu F, Kular J, Millward M, Iacopetta B.
    Pathology; 2012 Jun 01; 44(4):357-9. PubMed ID: 22614711
    [Abstract] [Full Text] [Related]

  • 18. BRAF mutation screening in melanoma: is sentinel lymph node reliable?
    Nardin C, Puzenat E, Prétet JL, Algros MP, Doussot A, Puyraveau M, Mougin C, Aubin F.
    Melanoma Res; 2015 Aug 01; 25(4):328-34. PubMed ID: 26020488
    [Abstract] [Full Text] [Related]

  • 19. T1799A BRAF mutations in conjunctival melanocytic lesions.
    Goldenberg-Cohen N, Cohen Y, Rosenbaum E, Herscovici Z, Chowers I, Weinberger D, Pe'er J, Sidransky D.
    Invest Ophthalmol Vis Sci; 2005 Sep 01; 46(9):3027-30. PubMed ID: 16123397
    [Abstract] [Full Text] [Related]

  • 20. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
    Gill M, Cohen J, Renwick N, Mones JM, Silvers DN, Celebi JT.
    Cancer; 2004 Dec 01; 101(11):2636-40. PubMed ID: 15503312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.